Senores Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 23/07/2025 ,inter alia, to consider and approve Un-audited Standalone ....
SENORES · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Senores Pharmaceuticals has informed the exchanges that its Board of Directors will meet on Wednesday, July 23, 2025. The key agenda is to consider and approve the Un-audited Standalone and Consolidated Financial Results for the quarter ended June 30, 2025 (Q1 FY26). The company also references its earlier intimation about the trading window for insiders being closed from July 1, 2025, until 48 hours after the results are announced. The letter is signed by Company Secretary Vinay Kumar Mishra.
This is a routine pre-results announcement. Investors should watch for the actual Q1 FY26 numbers on July 23, 2025, which will be the first real datapoint for the quarter. No immediate price action is expected from the intimation itself.